Literature DB >> 28778857

Methodological and Ethical Issues in Pediatric Medication Safety Research.

Delesha Carpenter1, Daniel Gonzalez2, George Retsch-Bogart3,4,5, Betsy Sleath6, Benjamin Wilfond7.   

Abstract

In May 2016, the Eshelman School of Pharmacy at The University of North Carolina at Chapel Hill convened the PharmSci conference to address the topic of "methodological and ethical issues in pediatric medication safety research." A multidisciplinary group of experts representing a diverse array of perspectives, including those of the US Food and Drug Administration, children's hospitals, and academia, identified important considerations for pediatric medication safety research and opportunities to advance the field. This executive summary describes current challenges that clinicians and researchers encounter related to pediatric medication safety research and identifies innovative and ethically sound methodologies to address these challenges to improve children's health. This article addresses 5 areas: (1) pediatric drug development and drug trials; (2) conducting comparative effectiveness research in pediatric populations; (3) child and parent engagement on study teams; (4) improving communication with children and parents; and (5) assessing child-reported outcomes and adverse drug events.
Copyright © 2017 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2017        PMID: 28778857      PMCID: PMC5574727          DOI: 10.1542/peds.2017-0195

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  42 in total

Review 1.  Paediatric clinical trials: redressing the imbalance.

Authors:  Mark S Schreiner
Journal:  Nat Rev Drug Discov       Date:  2003-12       Impact factor: 84.694

2.  IMPACCT Kids' Care: a real-world example of stakeholder involvement in comparative effectiveness research.

Authors:  Sonja Likumahuwa-Ackman; Heather Angier; Aleksandra Sumic; Rose L Harding; Erika K Cottrell; Deborah J Cohen; Christine A Nelson; Timothy E Burdick; Lorraine S Wallace; Charles Gallia; Jennifer E DeVoe
Journal:  J Comp Eff Res       Date:  2015-08       Impact factor: 1.744

Review 3.  Design and conduct of early phase drug studies in children: challenges and opportunities.

Authors:  Michael Rieder; Daniel Hawcutt
Journal:  Br J Clin Pharmacol       Date:  2016-08-08       Impact factor: 4.335

Review 4.  The role of effective communication with children and their families in fostering adherence to pediatric regimens.

Authors:  M Robin Dimatteo
Journal:  Patient Educ Couns       Date:  2004-12

5.  Clinical Trial Simulations and Pharmacometric Analysis in Pediatrics: Application to Inhaled Loxapine in Children and Adolescents.

Authors:  Min Dong; Tsuyoshi Fukuda; Sally Selim; Mark A Smith; Laura Rabinovich-Guilatt; James V Cassella; Alexander A Vinks
Journal:  Clin Pharmacokinet       Date:  2017-10       Impact factor: 6.447

6.  Drug labeling and exposure in neonates.

Authors:  Matthew M Laughon; Debbie Avant; Nidhi Tripathi; Christoph P Hornik; Michael Cohen-Wolkowiez; Reese H Clark; P Brian Smith; William Rodriguez
Journal:  JAMA Pediatr       Date:  2014-02       Impact factor: 16.193

7.  Caveats for the use of operational electronic health record data in comparative effectiveness research.

Authors:  William R Hersh; Mark G Weiner; Peter J Embi; Judith R Logan; Philip R O Payne; Elmer V Bernstam; Harold P Lehmann; George Hripcsak; Timothy H Hartzog; James J Cimino; Joel H Saltz
Journal:  Med Care       Date:  2013-08       Impact factor: 2.983

8.  Collaborative Chronic Care Networks (C3Ns) to transform chronic illness care.

Authors:  Peter A Margolis; Laura E Peterson; Michael Seid
Journal:  Pediatrics       Date:  2013-06       Impact factor: 7.124

9.  Communication during pediatric asthma visits and self-reported asthma medication adherence.

Authors:  Betsy Sleath; Delesha M Carpenter; Catherine Slota; Dennis Williams; Gail Tudor; Karin Yeatts; Stephanie Davis; Guadalupe X Ayala
Journal:  Pediatrics       Date:  2012-09-03       Impact factor: 7.124

10.  'Wicked problems', community engagement and the need for an implementation science for research ethics.

Authors:  James V Lavery
Journal:  J Med Ethics       Date:  2016-08-18       Impact factor: 2.903

View more
  2 in total

Review 1.  Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines.

Authors:  Michael R Pranzatelli
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

2.  Paediatric clinical research in Europe: an insight on experts' needs and perspectives.

Authors:  Lucia Ruggieri; Adriana Ceci; Franco Bartoloni; Valèry Elie; Mariagrazia Felisi; Evelyne Jacqz-Aigrain; Mariangela Lupo; Salma Malik; Cristina Manfredi; Giorgio Reggiardo; Jacques Demotes; Donato Bonifazi
Journal:  Contemp Clin Trials Commun       Date:  2021-02-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.